# Cardiovascular Diabetology

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/cardiovascular-diabetology/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 3,690 |
| Citations | 186,762 |
| h-index | 168 |
| Homepage | http://www.cardiab.biomedcentral.com/ |
| Open Access | true |
| ISSN-L | 1475-2840 |
| ISSNs | 1475-2840 |
| OpenAlex ID | https://openalex.org/S12095120 |
| Publisher | BioMed Central |
| Works | 4,091 |

## Journal papers

Showing 12 of 67.

- [SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart](https://scholariq.org/papers/sglt2-inhibition-with-empagliflozin-attenuates-myocardial-oxidative-stress-and/)
- [The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus](https://scholariq.org/papers/the-effect-of-empagliflozin-on-arterial-stiffness-and-heart-rate-variability-in/)
- [Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care](https://scholariq.org/papers/triglyceride-glucose-index-is-associated-with-symptomatic-coronary-artery/)
- [Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats](https://scholariq.org/papers/empagliflozin-a-sodium-glucose-co-transporter-2-inhibitor-alleviates-atrial/)
- [Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus](https://scholariq.org/papers/relationship-between-fluctuations-in-glucose-levels-measured-by-continuous/)
- [GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs](https://scholariq.org/papers/glp-1-receptor-agonists-and-cardiorenal-outcomes-in-type-2-diabetes-an-updated/)
- [Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state](https://scholariq.org/papers/obstructive-sleep-apnoea-is-independently-associated-with-the-metabolic-syndrome/)
- [Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study](https://scholariq.org/papers/estimated-glucose-disposal-rate-and-risk-of-stroke-and-mortality-in-type-2/)
- [Insulin resistance assessed by estimated glucose disposal rate and risk of incident cardiovascular diseases among individuals without diabetes: findings from a nationwide, population based, prospective cohort study](https://scholariq.org/papers/insulin-resistance-assessed-by-estimated-glucose-disposal-rate-and-risk-of/)
- [Gender difference in the association between TyG index and subclinical atherosclerosis: results from the I-Lan Longitudinal Aging Study](https://scholariq.org/papers/gender-difference-in-the-association-between-tyg-index-and-subclinical/)
- [The role of interleukin-18 in the metabolic syndrome](https://scholariq.org/papers/the-role-of-interleukin-18-in-the-metabolic-syndrome/)
- [Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis](https://scholariq.org/papers/association-of-sglt2-inhibitors-with-cardiovascular-kidney-and-safety-outcomes/)

## Journal top topics

Showing 8 of 25.

- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Adipokines, Inflammation, and Metabolic Diseases](https://scholariq.org/topics/adipokines-inflammation-and-metabolic-diseases/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)
- [Cardiovascular Disease and Adiposity](https://scholariq.org/topics/cardiovascular-disease-and-adiposity/)
- [Cardiovascular Health and Disease Prevention](https://scholariq.org/topics/cardiovascular-health-and-disease-prevention/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.